Peptide receptor radionuclide therapy as neoadjuvant treatment in pancreatic neuroendocrine tumours

被引：0
|
作者：
Prospero, I. [1 ]
Ferreira, G. [1 ]
Ferro, J. C. [1 ]
Barbosa, D. [1 ]
Silva, D. G. [1 ]
Fontao de Castro, S. [1 ]
Teixeira, J. P. [1 ]
Duarte, H. [1 ]
Lucena Sampaio, I. [1 ]
机构：
[1] Inst Portugues Oncol Porto, Porto, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-473
引用
收藏
页码：S220 / S220
页数：1
相关论文
共 50 条
  • [21] PEPTIDE RECEPTOR RADIONUCLIDE THERAPY FOR METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
    Potter, Samara
    Johnston, Danielle
    Mahajan, Priya
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [22] Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours
    Samuel Adant
    Girish M. Shah
    Jean-Mathieu Beauregard
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 907 - 921
  • [23] Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
    Elston, Marianne S.
    Love, Amanda
    Kevat, Dev
    Carroll, Richard
    Siow, Zhen Rong
    Pattison, Sharon
    Boyle, Veronica
    Segelov, Eva
    Strickland, Andrew H.
    Wyld, David
    Gauci, Richard
    Kennedy, Kim
    Ransom, David
    CANCER MEDICINE, 2021, 10 (23): : 8405 - 8411
  • [24] The role of peptide receptor radionuclide therapy in patients with lung neuroendocrine tumours
    Filice, Angelina
    Fraternali, Alessandro
    Fioroni, Federica
    Froio, Armando
    Di Paolo, Maria Liberata
    Casali, Massimiliano
    Roncali, Massimo
    Grassi, Elisa
    Asti, Mattia
    Versari, Annibale
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [25] Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?
    Michael S. Hofman
    Rodney J. Hicks
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 211 - 213
  • [26] Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?
    Hofman, Michael S.
    Hicks, Rodney J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (02) : 211 - 213
  • [27] Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours
    Adant, Samuel
    Shah, Girish M.
    Beauregard, Jean-Mathieu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (04) : 907 - 921
  • [28] Peptide Receptor Radionuclide Therapy (PRRT) a Novel Option as Neoadjuvant Therapy for Pancreatic Neuroendocrine Tumors: A Surgical Series
    Miotto, M.
    Nessi, C.
    Cingarlini, S.
    Severi, S.
    Paganelli, G.
    Malleo, G.
    D'Onofrio, M.
    Pea, A.
    Vincenzi, S.
    Scarpa, A.
    Salvia, R.
    Landoni, L.
    NEUROENDOCRINOLOGY, 2019, 108 : 254 - 254
  • [29] Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT)
    Marco Schiavo Lena
    Stefano Partelli
    Paola Castelli
    Valentina Andreasi
    Chanel Elisha Smart
    Eleonora Pisa
    Mirco Bartolomei
    Emilio Bertani
    Giuseppe Zamboni
    Massimo Falconi
    Claudio Doglioni
    Endocrine Pathology, 2020, 31 : 119 - 131
  • [30] Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
    Kwekkeboom, Dik J.
    Krenning, Eric P.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (01) : 179 - +
12345